Authors: Kagen, MH Ruhl, KK Aghajanian, C Myskowski, PL

Citation: Mh. Kagen et al., Squamous cell carcinoma of the cervix metastatic to the skin, J AM ACAD D, 45(1), 2001, pp. 133-135

Authors: Hensley, ML Hoppe, B Leon, L Sabbatini, P Aghajanian, C Chi, D Spriggs, DR

Citation: Ml. Hensley et al., The costs and efficacy of liposomal doxorubicin in platinum-refractory ovarian cancer in heavily pretreated patients, GYNECOL ONC, 82(3), 2001, pp. 464-469

Authors: Maluf, FC Sabbatini, P Schwartz, L Xia, JR Aghajanian, C

Citation: Fc. Maluf et al., Endometrial stromal sarcoma: Objective response to letrozole, GYNECOL ONC, 82(2), 2001, pp. 384-388

Authors: Makhija, S Sabbatini, P Aghajanian, C Venkatraman, E Spriggs, DR Barakat, R

Citation: S. Makhija et al., Intraperitoneal cisplatin and intravenous paclitaxel in the treatment of epithelial ovarian cancer patients with a positive second look, GYNECOL ONC, 79(1), 2000, pp. 28-32

Authors: Sabbatini, PJ Kudryashov, V Ragupathi, G Danishefsky, SJ Livingston, PO Bornmann, W Spassova, M Zatorski, A Spriggs, D Aghajanian, C Soignet, S Peyton, M O'Flaherty, C Curtin, J Lloyd, KO

Citation: Pj. Sabbatini et al., Immunization of ovarian cancer patients with a synthetic Lewis(Y)-protein conjugate vaccine: A phase 1 trial, INT J CANC, 87(1), 2000, pp. 79-85

Authors: Husain, A Sabbatini, P Spriggs, D Fennelly, D Aghajanian, C Barakat, R Curtin, J Venkatraman, E Hoskins, W Markman, M

Citation: A. Husain et al., Phase II trial of intraperitoneal cisplatin and mitoxantrone in patients with persistent ovarian cancer, GYNECOL ONC, 73(1), 1999, pp. 96-101